An investigation of formulation factors affecting feasibility of alginate-chitosan microparticles for oral delivery of naproxen
- 284 Downloads
In the present work we investigated the feasibility of chitosan treated Ca-alginate microparticles for delivery of naproxen in lower parts of GIT and evaluated influence of formulation factors on their physicochemical characteristics and drug release profiles. Investigated factors were drug/polymer ratio, chitosan molecular weight, chitosan concentration in hardening medium, and hardening time. Sixteen microparticle formulations were prepared utilizing 24 full factorial design (each factor was varied at two levels). Microparticles size varied between 262.3 ± 14.9 and 358.4 ± 21.7 μm with slightly deformed spherical shape. Low naproxen solubility and rapid reaction of ionotropic gelation resulted in high encapsulation efficiency (> 75.19%). Under conditions mimicking those in the stomach, after two hours, less than 6.18% of naproxen was released. Significant influence of all investigated factors on drug release rate was observed in simulated small intestinal fluid. Furthermore, experimental design analysis revealed that chitosan molecular weight and its concentration had the most pronounced effect on naproxen release. Release data kinetics indicated predominant influence of a pH-dependent relaxation mechanism on drug release from microparticles.
Key wordsNaproxen Alginate-chitosan microparticles Experimental design Sustained release
Unable to display preview. Download preview PDF.
- Cekić, N. D., Milić, J. R., Savić, S. D., Savić, M. M., Jović, Z., and Daniels, R., Influence of the preparation procedure and chitosan type on physicochemical properties and release behavior of alginate-chitosan microparticles. Drug Dev. Ind. Pharm., 35, 1092–1102 (2009).PubMedCrossRefGoogle Scholar
- Dai, Y. N., Li, P., Zhang, J. P., Wang, A. Q., and Wei, Q., Swelling characteristics and drug delivery properties of nifedipine-loaded pH sensitive alginate-chitosan hydrogel beads. J. Biomed. Mater. Res. B Appl. Biomater., 86, 493–500 (2008).Google Scholar
- Eskilson, C., Controlled release by microencapsulation. Manufacturing Chemist., 56, 33–39 (1985).Google Scholar
- Ferreira, A. P. and Almeida, A. J., Cross-linked alginategelatine beads: a new matrix for controlled release of pindolol. J. Control. Release, 97, 431–439 (2004).Google Scholar
- Kramer, J. and Blume, H., Biopharmaceutical aspects of multiparticulates. In Ghebre-Sellasie, Y. (Ed.). Multiparticulate Oral Drug Delivery. Marcel Dekker, New York, pp. 307–332, (1994).Google Scholar
- Sweetman, S. C., Martindale: The Complete Drug Reference. Pharmaceutical Press, London, pp. 60, (2002).Google Scholar